Demographic differences among patients treated with chimeric antigen receptor <scp>T‐cell</scp> therapy in the United States

Abstract

CART therapy recipients in the United States were more likely to be Whites and more likely to be residents of metropolitan areas. These observed demographic differences were not associated with treatment outcomes or inhospital mortalities.